Form 4: Director Kurt J. Hilzinger Increases Humana Equity Stake
Statement of Changes in Beneficial Ownership
Director Kurt J. Hilzinger acquired 536 restricted stock units in Humana Inc. as part of a director fee conversion.
Summary
- Director Kurt J. Hilzinger acquired 536 restricted stock units (RSUs) of Humana Inc. common stock.
- The transaction occurred on March 31, 2026, at a price of $170.6605 per unit.
- The acquisition represents a conversion of director cash fees into deferred stock units.
- Following this transaction, the reporting person holds 16,301 RSUs in this specific category, alongside other holdings.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not impact the company's operational outlook.
Positives
- Demonstrates alignment of interest between the director and shareholders through increased equity-based compensation.
- Reflects confidence in the company's long-term value by electing to receive fees in stock units.
Negatives
- None identified; this is a standard director compensation transaction.
Risks
- The value of the deferred stock units is subject to the future market performance of Humana Inc. common stock.
Future Outlook
The stock units are deferred until the director's resignation of services, at which point they will be payable in Humana Inc. common stock on a 1-for-1 basis.
Management Comments
- The transaction is exempt pursuant to Rule 16(b)-3(d)(1) as it relates to the election of director fees into stock units.
Industry Context
StockSavvy.ai notes that director fee-to-equity conversions are a standard corporate governance practice in the healthcare insurance sector, signaling board commitment to long-term equity performance.
Comparison to Industry Standards
- The use of deferred stock units for director compensation is consistent with standard practices at large-cap healthcare companies like UnitedHealth Group and CVS Health.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Conversion of cash director fees into deferred stock units. | 03/31/2026 | Neutral; aligns director compensation with shareholder interests. |
Stakeholder Impact
- Shareholders: Minimal impact; reflects standard director compensation structure.
Next Steps
- The director will continue to hold these units until resignation of services.
Key Dates
| Date | Description |
|---|---|
| 03/31/2026 | Date of the reported transaction involving the acquisition of stock units. |
| 04/02/2026 | Date the Form 4 was signed and filed with the SEC. |
Keywords
Humana, HUM, Director Compensation, Insider Trading, Restricted Stock Units, Equity Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.